Ambrisentan CAS 177036-94-1
Identification
Properties
Safety Data
Specifications & Other Information
Links
Identification
CAS Number
177036-94-1
Name
Ambrisentan
Synonyms
(2S)-2-[(4,6-Dimethyl-2-pyrimidinyl)oxy]-3-methoxy-3,3-diphenylpropanoic acid [ACD/IUPAC Name]
(2S)-2-[(4,6-Dimethyl-2-pyrimidinyl)oxy]-3-methoxy-3,3-diphenylpropansäure [German] [ACD/IUPAC Name]
(2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropanoic acid
177036-94-1 [RN]
8128
Acide (2S)-2-[(4,6-diméthyl-2-pyrimidinyl)oxy]-3-méthoxy-3,3-diphénylpropanoïque [French] [ACD/IUPAC Name]
acide (2S)-2-[(4,6-diméthylpyrimidin-2-yl)oxy]-3-méthoxy-3,3-diphénylpropanoïque [French]
ambrisentan [INN] [Wiki]
ambrisentan [French] [INN]
ambrisentán [Spanish] [INN]
ambrisentanum [Latin] [INN]
Benzenepropanoic acid, α-[(4,6-dimethyl-2-pyrimidinyl)oxy]-β-methoxy-β-phenyl-, (αS)- [ACD/Index Name]
HW6NV07QEC
أمبريسنتان [Arabic] [INN]
安立生坦 [Chinese] [INN]
(2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-di(phenyl)propanoic acid
(2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-di(phenyl)propionic acid
(2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid
(2S)-2-[(4,6-dimethyl-2-pyrimidinyl)oxy]-3-methoxy-3,3-di(phenyl)propanoic acid
(2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic acid
(a-S)-a-[(4,6-Dimethyl-2-pyrimidinyl)oxy]-b-methoxy-b-phenylbenzenepropanoic acid
(S)-2-((4,6-Dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic acid
(S)-2-(4,6-Dimethylpyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropanoic acid
(S)-2-(4,6-Dimethyl-pyrimidin-2-yloxy)-3-methoxy-3,3-diphenyl-propionic acid
(S)-2-[(4,6-Dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropionic Acid
????????????api
[177036-94-1]
‘177036-94-1
713516-99-5 [RN]
ambrisentan???2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-di(phenyl)propanoic acid
AMBRISENTAN-D5
Benzenepropanoic acid, a-[(4,6-dimethyl-2-pyrimidinyl)oxy]-??-methoxy-??-phenyl-, (aS)-
Benzenepropanoic acid, a-[(4,6-dimethyl-2-pyrimidinyl)oxy]-�-methoxy-�-phenyl-, (aS)-
Benzenepropanoic acid, a-[(4,6-dimethyl-2-pyrimidinyl)oxy]-ß-methoxy-ß-phenyl-, (aS)-
BSF 208075
BSF 208075;AMBRISENTAN
BSF 208075;LU 208075;BSF208075;BSF-208075;LU208075;LU-208075
BSF208075
Letairis
Letairis®
LU208075
MFCD08672619 [MDL number]
MFCD09842330 [MDL number]
QA-7701
UNII:HW6NV07QEC
UNII-7B43003091
UNII-HW6NV07QEC
Volibris
Molecular Structure
SMILES
Cc1cc(nc(n1)O[C@H](C(=O)O)C(c2ccccc2)(c3ccccc3)OC)C
StdInChI
InChI=1S/C22H22N2O4/c1-15-14-16(2)24-21(23-15)28-19(20(25)26)22(27-3,17-10-6-4-7-11-17)18-12-8-5-9-13-18/h4-14,19H,1-3H3,(H,25,26)/t19-/m1/s1
StdInChIKey
OUJTZYPIHDYQMC-LJQANCHMSA-N
Molecular Formula
C22H22N2O4
Molecular Weight
378.42
MDL Number
MFCD08672619
Properties
Refractive Index
1.593
Boiling Point
551.1±60.0 °C at 760 mmHg
Flash Point
287.1±32.9 °C
Density
1.2±0.1 g/cm3
Specifications and Other Information of Our Ambrisentan CAS 177036-94-1
Standard
Enterprise standard
GMP
LCFDA
Basic Patent Situation
| US expiry date | 20180729 |
| EU expiry date | 20201007 |
| JP expiry date | 20181211 |
Package
According to customer requirements to packaging
Storage
Under the room temperature and away from light
Application
Used as Anti-hypertensive
Links
Caming Pharmaceutical Ltd
This product is developed by our sub R&D company Caming Pharmaceutical Ltd, and please click the link below for details.
http://caming.com/ambrisentan-cas-177036-94-1/
Watson International Ltd
This product is sold exclusively through our sales company Watson International Ltd, and please click the link below for details.
http://watson-int.com/ambrisentan-cas-177036-94-1/